Collaboration - September 6, 2021
University of Helsinki collaborates with Boehringer Ingelheim
The Neuroscience Center of the University of Helsinki has entered into a research collaboration with Boehringer Ingelheim on human translational models. The target of the collaboration is to accelerate innovative gene therapy for brain diseases with high medical need. The collaborators will work on improving human brain organoid models to study central nervous system (CNS) […]
Biotech Business - August 18, 2021
Cereno Scientific collaborates with Abbott
Cereno Scientific has announced that a collaboration agreement has been entered with Abbott regarding use of its CardioMEMS HF System in the upcoming Phase II study with Cereno’s drug candidate CS1. The technology will be used to remotely and continously monitor the pulmonary pressure in the Phase II study evaluating CS1 for the treatment of […]
Collaboration - August 11, 2021
Lundbeck enters new research collaboration
Lundbeck will work together with the US-based Rgenta Therapeutics to discover small molecules targeting RNA regulation and splicing of disease-causing genes. “With this strategic R&D collaboration with Rgenta, we continue to supplement our research activities across the value chain. By using Rgenta’s platform capabilities in discovering RNA-targeting small molecules, we aim to pursue novel targets […]
Collaboration - August 9, 2021
AstraZeneca and Regeneron collaborate
AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialize small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities. The companies will evenly split research and development costs and share equally in any future potential profits. “We are pleased to announce this important collaboration […]
Collaboration - July 8, 2021
Cyxone collaborate with the Medical University of Vienna
After identifying some valuable new potential treatments for T20K, Cyxone has entered into a research collaboration with Prof. Christian Gruber, the inventor of T20K & Prof Gernot Schabbauer from the Medical University of Vienna. The aim of the study is to deepen the understanding of the mode of action (MoA) of T20K and to explore […]
Collaboration - June 22, 2021
Orion to co-develop CAR T-cell cancer therapy
Orion Corporation and the Finnish Red Cross Blood Service have concluded an agreement on research collaboration with the aim of developing chimeric antigen receptor (CAR) T-cell therapy. The Blood Service has experience in cell research, in the supply of cord blood and stem cell grafts classified as tissue products, and in the preparation of ATMP […]
